Backed by data from the phase 3 SatraGO trials, satralizumab has the potential to offer patients a convenient, at-home treatment option.
The pros, cons, price and what to ...
CNW/ - UCB Canada Inc. announced today the company has entered into Product Listing Agreements with British Columbia, Quebec, ...